Abstract
The use of Fentiazac, a nonsteroid anti-inflammatory agent endowed with a high prostaglandin-inhibiting activity, demonstrated a highly significant therapeutic activity in a controlled trial, carried out versus placebo, on 40 patients affected with essential dysmenorrhea.
| Translated title of the contribution | Controlled trial with a prostaglandin-inhibiting non-steroid anti-inflammatory agent in essential dysmenorrhea |
|---|---|
| Original language | Italian |
| Pages (from-to) | 791-796 |
| Number of pages | 6 |
| Journal | Minerva Ginecologica |
| Volume | 34 |
| Issue number | 10 |
| Publication status | Published - 1982 |
ASJC Scopus subject areas
- Obstetrics and Gynaecology